Emily M. Leproust is the President and CEO of Twist Bioscience Corporation, where she’s been making waves in the biotechnology field since 2015. She holds a Ph.D. in Chemistry from UC Berkeley, which lays a strong foundation for her leadership...

Emily M. Leproust is the President and CEO of Twist Bioscience Corporation, where she’s been making waves in the biotechnology field since 2015. She holds a Ph.D. in Chemistry from UC Berkeley, which lays a strong foundation for her leadership in a company that specializes in synthetic DNA technology. Under her guidance, Twist Bioscience has seen impressive growth, achieving a revenue growth rate that significantly outpaces industry averages. In 2023, her total compensation was about $800,000, making her one of the more notable figures in biotech leadership. Emily's hands-on approach includes a focus on tangible performance metrics like revenue growth, ensuring that her team is aligned with the company's goals. Notably, she has taken no stock grants in preparation periods focusing instead on cash compensation and performance-related bonuses, a move that indicates she’s putting the company’s success first. With her strategic mindset, Emily continues to drive innovation and expansion at Twist, making it a key player in the biotech industry.